Riskpilot← Back to searchSign inGet full accessDEKON CHEMICALS AS
ASActiveOrg 923797599Markens Gate 30, 4611 Kristiansand SEngineering activities and related technical consultancy · NACE 7112Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
-547% vs 2023
Equity ratio
-2.3%
Financial strength
Net profit 2024
NOK -36K
-547% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -36K | -547% |
| Net profit | NOK -36K | -547% |
| Total assets | NOK 788K | -7% |
| Equity | NOK -18K | -203% |
| Employees | 0 | — |
Legal name
DEKON CHEMICALS AS
Org number
923797599
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
8. november 2019
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikling, import og salg av biologiske rensemidler. Samt hva dermed står i forbindelse.
Address
Markens Gate 30, 4611 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 359 | 265 | 53 | 106 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | 8 | −6 | −36 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 8 | −6 | −36 |
| Net financials | −0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 8 | −6 | −36 |
| Tax | 0 | 3 | −0 | −0 | −0 |
| Net profit | 0 | −3 | 8 | −6 | −36 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 708 | 706 | 828 | 846 | 788 |
| Equity | 19 | 16 | 23 | 18 | −18 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 689 | 691 | 805 | 829 | 806 |
| Total debt | 689 | 691 | 805 | 829 | 806 |
EBITDA margin
-3598600.0%
This company
15.8%
Market median
-22776049% vs market
20202024
Equity ratio
-2.3%
This company
38.2%
Market median
-106% vs market
20202024
Return on equity
-3598600.0%
This company
18.4%
Market median
-19557709% vs market
20202024
Net profit margin
-3598600.0%
This company
8.1%
Market median
-44427260% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
44.08×
This company
0.62×
Market median
-7010% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PB Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90% | 90% | 2022 | |
| Company | 5% | 5% | 2022 | |
| Company | 5% | 5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Aspelund Holding As
DEKON CHEMICALS AS Board members of DEKON CHEMICALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pål Berg Aspelund | Chief Executive Officer | 0 companies |
| Rune Byremo | Board of Directors | 0 companies |
| Dag Rune Løvdal | Board of Directors | 0 companies |